Christopher Anzalone
Chief Executive Officer presso ARROWHEAD PHARMACEUTICALS, INC.
Patrimonio netto: 106 M $ in data 31/03/2024
Profilo
Christopher Richard Anzalone è un uomo d'affari che ha fondato Benet Group LLC e Nanotope, Inc. e che è stato a capo di 5 diverse aziende. Attualmente è presidente, amministratore delegato e direttore di Arrowhead Pharmaceuticals, Inc. e presidente e amministratore delegato di Calando Pharmaceuticals, Inc. (una filiale di Arrowhead Pharmaceuticals, Inc.). Il Dr. Anzalone è anche nel consiglio di amministrazione di altre 5 società. Nella sua carriera passata il dott. Anzalone è stato amministratore delegato di NanoInk, Inc., partner di Galway Partners LLC, presidente, amministratore delegato e direttore di Nanotope, Inc. e amministratore delegato di Benet Group LLC. Christopher Richard Anzalone ha conseguito un dottorato presso la University of California, Los Angeles e una laurea presso la Lawrence University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/01/2024 | 3 715 048 ( 3.00% ) | 106 M $ | 31/03/2024 |
Posizioni attive di Christopher Anzalone
Società | Posizione | Inizio |
---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Chief Executive Officer | 01/12/2007 |
Unidym, Inc.
Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Director/Board Member | 15/02/2010 |
Ablaris Therapeutics, Inc. | Director/Board Member | - |
Tego Biosciences Corp. | Director/Board Member | - |
Arrowhead Madison, Inc. | Director/Board Member | - |
Precedenti posizioni note di Christopher Anzalone
Società | Posizione | Fine |
---|---|---|
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | President | 01/01/2004 |
Galway Partners LLC | Corporate Officer/Principal | 01/01/2003 |
KRONOS BIO, INC. | Director/Board Member | - |
VIR BIOTECHNOLOGY, INC. | Director/Board Member | - |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Christopher Anzalone
University of California, Los Angeles | Doctorate Degree |
Lawrence University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Aziende private | 10 |
---|---|
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | Producer Manufacturing |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
Nanotope, Inc.
Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Nanotope, Inc. developed pharmaceutical products. The firm's products were used to regenerate specific tissues including neuronal, vascular, bone, myocardial, and cartilage. Its products targeted regeneration for prevention of paralysis associated with spinal cord injury and angiogenesis for advanced wound healing and the treatment of peripheral artery disease. The company was founded by Samuel I. Stupp and Christopher R. Anzalone and was headquartered in Skokie, IL. | Health Technology |
Roche Madison, Inc.
Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI. | Health Technology |
Unidym, Inc.
Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Electronic Technology |
Benet Group LLC
Benet Group LLC Financial ConglomeratesFinance Part of Arrowhead Pharmaceuticals, Inc., Benet Group LLC is a private equity firm. The private company is based in Washington. The American company was founded by Christopher Richard Anzalone. Benet Group was acquired by Arrowhead Pharmaceuticals, Inc. on March 13, 2008. | Finance |
Galway Partners LLC | Finance |
Ablaris Therapeutics, Inc. | |
Tego Biosciences Corp. | |
Arrowhead Madison, Inc. |
- Borsa valori
- Insiders
- Christopher Anzalone